CD6 and colorectal carcinoma: Unexpectedly, human T cells expressing the CD6-CAR showed cytotoxicity effects only against CD166/ALCAM-positive human CRC-derived cell lines, inferring that the cytotoxic activity correlated with CD166/ALCAM but not CD318/CDCP1 expression [58].